IRIS
FARINA, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.625
NA - Nord America 1.129
AS - Asia 1.037
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 90
AF - Africa 16
AN - Antartide 1
Totale 4.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.069
RU - Federazione Russa 782
CN - Cina 378
SG - Singapore 359
RO - Romania 264
IT - Italia 203
SE - Svezia 115
BR - Brasile 114
HK - Hong Kong 90
DE - Germania 78
VN - Vietnam 74
FR - Francia 54
GB - Regno Unito 41
BD - Bangladesh 40
CA - Canada 37
FI - Finlandia 26
IN - India 25
NL - Olanda 16
MX - Messico 14
PL - Polonia 12
JP - Giappone 11
AR - Argentina 10
IQ - Iraq 10
AT - Austria 8
PH - Filippine 8
ID - Indonesia 7
TR - Turchia 7
ZA - Sudafrica 7
IE - Irlanda 6
CO - Colombia 5
EG - Egitto 5
LT - Lituania 5
ES - Italia 4
UA - Ucraina 4
NP - Nepal 3
PK - Pakistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BE - Belgio 2
CR - Costa Rica 2
GT - Guatemala 2
IR - Iran 2
MD - Moldavia 2
MY - Malesia 2
PY - Paraguay 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AQ - Antartide 1
BG - Bulgaria 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
PE - Perù 1
SC - Seychelles 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 3.945
Salva come PNG Salva come JPEG
Città #
Dallas 220
Singapore 188
Moscow 154
Ashburn 140
San Jose 123
Hong Kong 88
Shanghai 73
Beijing 66
Milan 49
Munich 47
New York 44
Council Bluffs 41
Hefei 36
Los Angeles 34
Ho Chi Minh City 33
Lauterbourg 32
Lawrence 20
Princeton 20
Rome 20
Santa Clara 20
Boardman 19
Orem 19
Helsinki 17
Montreal 14
São Paulo 14
Atlanta 13
Warsaw 11
Hanoi 10
Toronto 10
Amsterdam 9
Boston 9
Chicago 9
Houston 9
Nuremberg 9
Pietra Ligure 8
Brooklyn 7
Cesano Boscone 7
Chennai 7
Guangzhou 7
London 7
Manchester 7
Tokyo 7
Denver 6
Frankfurt am Main 6
Johannesburg 6
Seattle 6
Turku 6
Mexico City 5
Miami 5
New Delhi 5
Shenzhen 5
Stockholm 5
Ancona 4
Ankara 4
Brescia 4
Newark 4
Pune 4
Quezon City 4
The Dalles 4
Baghdad 3
Baie-D'Urfé 3
Ballincollig 3
Barnet 3
Bexley 3
Bologna 3
Buffalo 3
Cairo 3
City of London 3
Da Nang 3
Dublin 3
Falkenstein 3
Genoa 3
Jundiaí 3
Las Vegas 3
Mumbai 3
Osimo 3
Paris 3
Poli 3
Poplar 3
Pottstown 3
Rio de Janeiro 3
Salvador 3
San Antonio 3
San Giuliano 3
Turin 3
Vittoria 3
York 3
Aobadai 2
Assago 2
Bauru 2
Belo Horizonte 2
Bismarck 2
Bosco Chiesanuova 2
Brunswick 2
Campinas 2
Castel Mella 2
Castellammare del Golfo 2
Concórdia 2
Dalmine 2
Dhaka 2
Totale 1.870
Salva come PNG Salva come JPEG
Nome #
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 395
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 203
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 179
Biobanking for COVID-19 research 149
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 130
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 127
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 121
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 120
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 119
Drug retention rates of biological agents in adult onset Still's disease 114
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 111
COVID-19: Pharmacology and kinetics of viral clearance 105
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 103
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 103
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 101
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 100
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 98
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 97
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies 96
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 96
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 96
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 95
Obesity and its role in the management of rheumatoid and psoriatic arthritis 93
Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies 93
Current treatment options and safety considerations when treating adult-onset Still’s disease 89
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 82
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 73
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 71
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 69
Secukinumab is not associated with cancer recurrence or progression in patients with spondyloarthritis and history of neoplastic disease 68
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 67
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 67
Low prevalence of arrhythmias in clinically stable COVID-19 patients 66
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 62
Loss of circulating CD8+ CD161high T cells in primary progressive multiple sclerosis 61
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 61
Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort 55
Interleukin 6 inhibition in severe COVID-19: Another piece of the puzzle 53
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 47
Totale 4.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.919
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 0 0 12 14 2 0 1 1 6 7 0 4
2022/2023216 50 43 16 6 12 25 20 25 4 2 6 7
2023/2024242 11 26 32 27 26 28 14 27 0 4 13 34
2024/2025909 56 15 21 28 42 50 358 66 92 36 47 98
2025/20262.455 169 167 183 286 181 66 203 197 687 148 68 100
2026/2027136 57 79 0 0 0 0 0 0 0 0 0 0
Totale 4.035